Comparison between meropenem and ceftolozane/tazobactam: possible influence of CRRT
Comparison between meropenem and ceftolozane/tazobactam: possible influence of CRRT
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
[...]it is reasonable to assume that most of these patients were undergoing renal replacement therapy (RRT), most likely continuous RRT (CRRT) though this was not reported [1]. The results suggest that the following ceftolozane/tazobactam doses, administered every 8 h according to renal function, are recommended for adults with HABP/VABP [7,8,9]: C...
Alternative Titles
Full title
Comparison between meropenem and ceftolozane/tazobactam: possible influence of CRRT
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_dd5b605caa194efd84fd480161bc85d7
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dd5b605caa194efd84fd480161bc85d7
Other Identifiers
ISSN
1364-8535
E-ISSN
1364-8535,1466-609X,1366-609X
DOI
10.1186/s13054-021-03837-6
